Cathie Wood’s ARK offloads Meta, boosts Intellia stock

Published 26/04/2025, 01:06
© Reuters

Cathie Wood’s ARK ETFs have made notable moves in the market on Friday, April 25, 2025, with a mix of both buying and selling across various sectors. The most significant trade of the day was the sale of 66,135 shares of Veracyte Inc (NASDAQ:VCYT), amounting to a substantial $2,125,578. This move comes as part of a recent trend, with ARK also reducing its position in Veracyte Inc in the previous sessions.

On the buying side, ARK’s ARKK ETF invested heavily in the biotech sector by purchasing 65,958 shares of Intellia Therapeutics Inc (NASDAQ:NTLA), with a total dollar value of $539,536. This acquisition indicates a growing interest in the gene-editing company, as ARK has been accumulating shares over the past week.

Another significant buy was Symbotic Inc (NASDAQ:SYM), where ARK’s ARKQ ETF added 8,140 shares worth $179,568. This automation technology company seems to be gaining ARK’s confidence, as this follows a smaller purchase earlier in the week.

In the technology sector, ARK’s ARKQ ETF bought 925 shares of Baidu Inc (NASDAQ:BIDU), totaling $82,787. Baidu, known as China’s Google (NASDAQ:GOOGL), has been another stock that ARK has been gradually adding to its portfolio.

However, not all trades were bullish. ARK’s ARKK ETF sold 1,255 shares of Meta Platforms Inc (NASDAQ:META), with a total dollar value of $669,103. This sale is a part of a continued reduction in the social media giant, which has been a trend for ARK in recent days.

Additionally, ARK’s ARKW ETF sold 984 shares of UiPath Inc (NYSE:PATH) for $11,138, further scaling down its investment in the automation software company, consistent with previous days’ activities.

Investors closely follow Cathie Wood’s ARK ETFs for their forward-looking investment strategies, particularly in disruptive technologies. Today’s trades underscore ARK’s dynamic approach to portfolio management, continuously adjusting positions to align with their vision of future market trends.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.